FCCC LOGO Faculty Publications
Tagai EK , Miller SM , Hudson SV , Diefenbach MA , Handorf E , Bator A , Marziliano A , Kutikov A , Hall SJ , Vira M , Schwartz M , Kim IY , Kim S
Improved cancer coping from a web-based intervention for prostate cancer survivors: A randomized controlled trial
Psychooncology. 2021 Apr 14;30(9) :1466-1475
Back to previous list
Abstract
OBJECTIVES: Prostate cancer (PCa) survivors report poor physical functioning alongside negative psychological outcomes as they cope with treatment side effects and practical concerns after treatment completion. This study evaluated PROGRESS, a web-based intervention designed to improve adaptive coping among PCa survivors. METHODS: Localized PCa patients (N = 431) within one year of treatment completion were randomized to receive educational booklets or PROGRESS + educational booklets. Surveys completed at baseline, 1-, 3-, and 6-months assessed patient characteristics; functional quality of life and coping (primary outcomes); and psychosocial outcomes (e.g., self-efficacy, marital communication; secondary outcomes). Intent-to-treat and as-treated analyses were completed to assess change in outcomes from baseline to 6 months using linear mixed effects regression models. RESULTS: In the intent-to-treat analyses, participants randomized to the intervention group had improved diversion coping (i.e., healthy redirection of worrying thoughts about their cancer), but more difficulties in marital communication (ps < 0.05). However, PROGRESS usage was low among those randomized to the intervention group (38.7%). The as-treated analyses found PROGRESS users reported fewer practical concerns but had worse positive coping compared to PROGRESS non-users (ps < 0.05). CONCLUSIONS: The findings suggest PROGRESS may improve certain aspects of adaptive coping among PCa survivors that use the website, but does not adequately address the remaining coping and psychosocial domains. Additional research is needed to better understand the gaps in intervention delivery contributing to low engagement and poor improvement across all domains of functional quality of life and adaptive coping.
Notes
1099-1611 Tagai, Erin K Miller, Suzanne M Orcid: 0000-0002-7296-9318 Hudson, Shawna V Diefenbach, Michael A Handorf, Elizabeth Bator, Alicja Marziliano, Allison Orcid: 0000-0002-4762-1416 Kutikov, Alexander Hall, Simon J Vira, Manish Schwartz, Michael Kim, Issac Yi Kim, Sung CA/NCI NIH HHS/United States TR/NCATS NIH HHS/United States CC/CDC HHS/United States American Cancer Society/ Journal Article England Psychooncology. 2021 Apr 14. doi: 10.1002/pon.5701.